In the 7MM (US, France, Germany, Italy, Spain, the UK, and Japan), of the most diagnosed incident cases of ovarian cancer are initially diagnosed in stage III. A diagnosis of ovarian cancer at stage III is considered to be an advanced diagnosis with a low five-year survival rate. Symptoms of ovarian cancer include bloating, pelvic or abdominal pain, and urinary symptoms such as urgency or frequency. The symptoms are not as noticeable in the early stages of ovarian cancer, compared to later stages.

Because early symptoms can be vague and nonspecific, ovarian cancer is often diagnosed at a later stage. GlobalData epidemiologists estimate that 40% of diagnosed incident cases of ovarian cancer were in stage III at initial diagnosis in the 7MM in 2018.

In 2018, diagnosed incident cases of ovarian cancer in stage III accounted for the highest proportion of cases in each market, followed by cases initially diagnosed in stage IV. Diagnosed incident cases of ovarian cancer diagnosed in stage II account for the lowest proportion in each market and the 7MM combined.

Diagnosing ovarian cancer at an earlier stage has been a research priority because cases diagnosed at an earlier stage have a higher rate of survival. Current research efforts include developing a screening test for ovarian cancer that examines protein patterns in blood. In addition to screening tests in development, researchers are studying genetic mutations and how detecting high-risk genes may help with prevention.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.